The Sky Shop For Hope
Viral Product Mystery Box
Viral Product Mystery Box
Couldn't load pickup availability
The $75 Viral Products Mystery Box brings you a curated selection of fun, trending items that have gone viral on Instagram and TikTok. Each month you’ll receive surprise products designed to entertain, delight, and keep you ahead of the trend.
What makes this box special? Every purchase directly supports Sky Foundation, a nonprofit dedicated to pancreatic cancer awareness and research. That means every viral gadget or unique item you open also helps fund life-saving work.
This subscription makes monthly giving fun and tangible. You’ll enjoy the thrill of opening new viral products while knowing your support is fueling research and awareness in the fight against pancreatic cancer.
FAQ Section
Q: What types of products are included in the Viral Products Mystery Box?
A: Each month features a curated mix of trending items seen on Instagram or TikTok. These are fun, practical, and unique products designed to surprise and delight.
Q: When will I receive my box?
A: Boxes ship monthly and typically arrive within 5–7 business days after shipping. You’ll get tracking information as soon as your order is on its way.
Q: How does my purchase help Sky Foundation?
A: Every $75 Mystery Box supports Sky Foundation, a nonprofit focused on raising awareness and funding research for pancreatic cancer. Your monthly giving makes a difference.
Share

Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...